1. Home
  2. CVKD vs BRN Comparison

CVKD vs BRN Comparison

Compare CVKD & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • BRN
  • Stock Information
  • Founded
  • CVKD 2022
  • BRN 1956
  • Country
  • CVKD United States
  • BRN United States
  • Employees
  • CVKD N/A
  • BRN N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • BRN Oil & Gas Production
  • Sector
  • CVKD Health Care
  • BRN Energy
  • Exchange
  • CVKD Nasdaq
  • BRN Nasdaq
  • Market Cap
  • CVKD 20.8M
  • BRN 16.9M
  • IPO Year
  • CVKD 2023
  • BRN N/A
  • Fundamental
  • Price
  • CVKD $19.72
  • BRN $1.80
  • Analyst Decision
  • CVKD Strong Buy
  • BRN
  • Analyst Count
  • CVKD 1
  • BRN 0
  • Target Price
  • CVKD $32.00
  • BRN N/A
  • AVG Volume (30 Days)
  • CVKD 51.3K
  • BRN 92.0K
  • Earning Date
  • CVKD 03-10-2025
  • BRN 02-10-2025
  • Dividend Yield
  • CVKD N/A
  • BRN N/A
  • EPS Growth
  • CVKD N/A
  • BRN N/A
  • EPS
  • CVKD N/A
  • BRN N/A
  • Revenue
  • CVKD N/A
  • BRN $21,724,000.00
  • Revenue This Year
  • CVKD N/A
  • BRN N/A
  • Revenue Next Year
  • CVKD N/A
  • BRN N/A
  • P/E Ratio
  • CVKD N/A
  • BRN N/A
  • Revenue Growth
  • CVKD N/A
  • BRN N/A
  • 52 Week Low
  • CVKD $5.40
  • BRN $1.31
  • 52 Week High
  • CVKD $21.30
  • BRN $3.20
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 59.55
  • BRN 57.20
  • Support Level
  • CVKD $19.07
  • BRN $1.78
  • Resistance Level
  • CVKD $19.56
  • BRN $2.03
  • Average True Range (ATR)
  • CVKD 1.48
  • BRN 0.13
  • MACD
  • CVKD 0.01
  • BRN 0.01
  • Stochastic Oscillator
  • CVKD 69.69
  • BRN 45.31

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.

Share on Social Networks: